QUESTION: Which was the first mutant IDH2 inhibitor to be approved for patients with acute myeloid leukemia?

IDEAL_ANSWER:
- Enasidenib was the first mutant IDH2 inhibitor to be approved for the treatment of refractory and relapsed acute myeloid leukemia.

EXACT_ANSWER:
- Enasidenib